Literature DB >> 18818526

Metastasis and AKT activation.

Meng Qiao1, Shijie Sheng, Arthur B Pardee.   

Abstract

Metastasis is responsible for 90% of cancer patient deaths. More information is needed about the molecular basis for its potential detection and treatment. The activated AKT kinase is necessary for many events of the metastatic pathway including escape of cells from the tumor's environment, into and then out of the circulation, activation of proliferation, blockage of apoptosis, and activation of angiogenesis. A series of steps leading to metastatic properties can be initiated upon activation of AKT by phosphorylation on Ser-473. These findings lead to the question of how this activation is connected to metastasis. Activated AKT phosphorylates GSK-3beta causing its proteolytic removal. This increases stability of the negative transcription factor SNAIL, thereby decreasing transcription of the transmembrane protein E-cadherin that forms adhesions between adjacent cells, thereby permitting their detachment. How is AKT hyperactivated in metastatic cells? Increased PI3K or TORC2 kinase activity- or decreased PHLPP phosphatase could be responsible. Furthermore, a positive feedback mechanism is that the decrease of E-cadherin lowers PTEN and thereby increases PIP3, further activating AKT and metastasis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18818526     DOI: 10.4161/cc.7.19.6784

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  96 in total

1.  Expression of GIV/Girdin, a metastasis-related protein, predicts patient survival in colon cancer.

Authors:  Mikel Garcia-Marcos; Barbara H Jung; Jason Ear; Betty Cabrera; John M Carethers; Pradipta Ghosh
Journal:  FASEB J       Date:  2010-10-25       Impact factor: 5.191

2.  N-cadherin expression is a potential survival mechanism of gefitinib-resistant lung cancer cells.

Authors:  Mai Yamauchi; Ikuyo Yoshino; Rui Yamaguchi; Teppei Shimamura; Masao Nagasaki; Seiya Imoto; Atsushi Niida; Fumiaki Koizumi; Takashi Kohno; Jun Yokota; Satoru Miyano; Noriko Gotoh
Journal:  Am J Cancer Res       Date:  2011-08-08       Impact factor: 6.166

3.  Functional genomics identifies drivers of medulloblastoma dissemination.

Authors:  Michael Mumert; Adrian Dubuc; Xiaochong Wu; Paul A Northcott; Steven S Chin; Carolyn A Pedone; Michael D Taylor; Daniel W Fults
Journal:  Cancer Res       Date:  2012-08-08       Impact factor: 12.701

4.  Akt as a victim, villain and potential hero in Parkinson's disease pathophysiology and treatment.

Authors:  Lloyd A Greene; Oren Levy; Cristina Malagelada
Journal:  Cell Mol Neurobiol       Date:  2011-03-10       Impact factor: 5.046

5.  Dysregulation of the PI3K/Akt signaling pathway affects cell cycle and apoptosis of side population cells in nasopharyngeal carcinoma.

Authors:  Danwei Zheng; Guangchao Zhu; Shan Liao; Wei Yi; Gengqiu Luo; Junyu He; Zhen Pei; Guiyuan Li; Yanhong Zhou
Journal:  Oncol Lett       Date:  2015-05-18       Impact factor: 2.967

6.  Fine-tuning AKT kinase activity through direct lysine methylation.

Authors:  Jianping Guo; Wenyi Wei
Journal:  Cell Cycle       Date:  2019-05-03       Impact factor: 4.534

7.  Pharmacological inhibition of polycomb repressive complex-2 activity induces apoptosis in human colon cancer stem cells.

Authors:  Yannick D Benoit; Mavee S Witherspoon; Kristian B Laursen; Amel Guezguez; Marco Beauséjour; Jean-Francois Beaulieu; Steven M Lipkin; Lorraine J Gudas
Journal:  Exp Cell Res       Date:  2013-04-12       Impact factor: 3.905

Review 8.  Impact of heat-shock protein 90 on cancer metastasis.

Authors:  Shinji Tsutsumi; Kristin Beebe; Len Neckers
Journal:  Future Oncol       Date:  2009-06       Impact factor: 3.404

9.  The expression of chitinase 3-like 1: a novel prognostic predictor for hepatocellular carcinoma.

Authors:  Jing-Jing Pan; Yong-Sheng Ge; Ge-Liang Xu; Wei-Dong Jia; Wei-Feng Liu; Jian-Sheng Li; Wen-Bin Liu
Journal:  J Cancer Res Clin Oncol       Date:  2013-03-23       Impact factor: 4.553

10.  The Akt activation inhibitor TCN-P inhibits Akt phosphorylation by binding to the PH domain of Akt and blocking its recruitment to the plasma membrane.

Authors:  N Berndt; H Yang; B Trinczek; S Betzi; Z Zhang; B Wu; N J Lawrence; M Pellecchia; E Schönbrunn; J Q Cheng; S M Sebti
Journal:  Cell Death Differ       Date:  2010-05-21       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.